Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2005The Journal of ImmunologyOpen Access

Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSigrid SandnerMedical University of ViennaMCMichael R. ClarksonBrigham and Women's HospitalASAlan D. SalamaThe Royal Free Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sandner et al. (2005) studied this question.

synapsesocial.com/papers/6a0170b98d267ec217d8a8f5https://doi.org/10.4049/jimmunol.174.6.3408
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells2004 · 647 citations
  2. 2Stimulating PD-1???negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival12003 · 160 citations
  3. 3Positive Selection Through a Motif in the αβ T Cell Receptor1998 · 108 citations
  4. 4Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses2003 · 644 citations
  5. 5T‐cell costimulatory pathways in allograft rejection and tolerance2003 · 222 citations